Why the study?
Does captopril reduce blood pressure and alter the renin-angiotensin system in patients with severe treatment-resistant hypertension?
Does captopril reduce blood pressure and alter the renin-angiotensin system in patients with severe treatment-resistant hypertension?
Captopril acutely reduces blood pressure and inhibits converting enzyme activity in severe treatment-resistant hypertension, though maintenance therapy often requires the addition of a diuretic.
Acute response in resistant hypertension supports further ACEI evaluation; leaves open maintenance without diuretics.
The effect of captopril on blood pressure (BP) and various components of the renin-angiotensin system was assessed in ten severely hypertensive patients. Captopril acutely reduced the BP with a maximum decrease of 23% at 90-120 min. Maintenance treatment with captopril alone could not control the BP in any of the patients. Addition of hydrochlorothiazide markedly reduced the BP, while supplementation with propranolol caused no consistent changes. Three patients attained a supine diastolic blood pressure (SDBP) less than or equal to 90 mmHg. Only two patients had a fall in SDBP less than 10 mmHg. One patient stopped because of taste disturbances. Monitoring the renin-angiotensin system showed suppressed plasma concentrations of angiotensin II and increased levels of angiotensin I and renin, indicating the inhibition of converting enzyme activity. Plasma concentration of renin substrate decreased significantly. This observation has important implications for the methodology of renin assays. Captopril is an effective alternative in the treatment of hypertensive patients not readily controlled with conventional therapy.
No takes yet. Share an insight, caveat, or question.
Rasmussen et al. (1984) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: